Filter
324
Filtered Results: 324
Text search:
mRNA
Featured
Recommendations
62
New Publications
9
Language
Document type
Guidelines
103
Fact sheets
65
Studies & Reports
42
No document type
37
Videos
29
Manuals
13
Resource Platforms
11
Strategic & Response Plan
9
Training Material
5
Infographics
5
Situation Updates
3
Brochures
1
Online Courses
1
Countries / Regions
Germany
23
Brazil
17
Russia
12
Global
11
Ukraine
9
Latin America and the Carribbean
9
Middle East and North Africa
7
India
7
South Africa
5
Ecuador
5
Syria
4
Nigeria
4
Argentina
4
Yemen
4
Senegal
3
Mozambique
3
Africa
3
Lebanon
3
Eastern Europe
3
China
2
Kazakhstan
2
Chile
2
Niger
2
Peru
2
Haiti
2
Western and Central Europe
2
Belarus
2
Uganda
2
Sudan
2
Mali
2
South Sudan
2
Somalia
2
Colombia
1
Kenya
1
Mexico
1
El Salvador
1
Benin
1
Sierra Leone
1
Rwanda
1
Cameroon
1
Congo-Brazzaville
1
Burkina Faso
1
Morocco
1
Qatar
1
Mauritania
1
Dominican Republic
1
Venezuela
1
Jordan
1
Saudi Arabia
1
Congo, Democratic Republic of
1
West and Central Africa
1
South–East Asia Region
1
Paraguay
1
France
1
Tunisia
1
United Kingdom
1
Spain
1
Israel
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Nicaragua
1
Egypt
1
Ethiopia
1
Honduras
1
Angola
1
Chad
1
Libya
1
Indonesia
1
Iraq
1
Liberia
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
COVID-19
85
Guidelines
35
Information, Education and Communication (IEC)
16
Policies
6
x MEDBOX Issue Brief & Annual Reports x
5
Cervical Cancer
5
Vaccine-preventable Diseases
5
Studies & Reports
5
Policies & Guidelines HIV & TB
4
Communicable Diseases
3
Capacity Building
3
TB
3
Cancer
2
Infection Control & Prevention (IPC)
2
Pediatrics
2
Humanitarian Crisis
2
Immunization
2
Health Systems
2
HIV & STI
2
Disease Prevention & Control
2
Hepatitis
1
Pharmacy & Technology
1
Disaster Preparedness
1
General Guidelines
1
MPOX - Monkeypox
1
Virology
1
Countries
1
Medical Devices & Equipment
1
Yellow Fever
1
Women & Child Health
1
Statistics
1
Communicable Diseases
1
Gynaecology & Obstetrics
1
Non-communicable Diseases
1
Malaria
1
Reproductive Health
1
Pharmacy & Technologies
1
Toolboxes
COVID-19 Vaccination Information
35
Country specific documents
33
Videos
32
Communication Material
30
Vaccine Hesitancy & Myths
26
Immunization Guidelines
24
COVID-19 Vaccination
23
Biontech/Pfizer Comirnaty
21
Access & Strategy
15
For Migrants & Refugees
13
Infection Control General
12
For General Public & Community
12
mRna Vaccines general
11
Moderna
11
Logistics & Supply
10
Inactivated COVID-19 Vaccines
10
Clinical Guidelines
9
SARS-CoV-2 Variants
9
Vector-based Vacines General
9
Booster Doses
9
Fair Allocation & Ethical Aspects
8
Vaxzevria (Astra Zeneca)
7
Surveillance & Contact tracing
6
COVID-19 Information
6
Dashboards & Resource Platforms
6
Research & Pipeline
6
Vaccination
5
For Health Worker
5
Vaccine Candidates & Research
5
Anamnesis / Screening
4
Training, others
4
For Older People
4
Scientific & Research Studies
4
Blood Supply
4
Guidelines & Manuals
4
Prevention & Preparedness
3
Poster & Infographics
3
For Pregnant Women
3
Global Impact: Socio-economic, health services, TB & HIV
3
Educational Settings
3
Workplace
3
Physical Distancing
3
Mythbusters/Misinformation
3
COVAX Initiative
3
Information Refugees Ukraine
3
COVID-19
3
Male Circumcision
2
General Reports
2
Vaccines & Immunization
2
PPE Personel Protective Equipment
2
Treatment Guidelines
2
Diagnostics & Laboratory Guidance
2
For Parents & Children
2
Information for the Public
2
HIV and COVID-19
2
Tips & Best Practice Examples
2
Vaccination & Strategy
2
Long COVID/ Post-COVID Syndrome
2
Johnson & Johnson
2
Covaxin
2
Pharmacovigilance
2
Situation Reports & Updates
2
General
2
Education material
2
Health Financing Toolbox
2
Drug resistant TB
2
Research & Access
2
Neurological disorders, Others
2
Gynaecology / Obstetrics
1
Laboratory Guidance
1
Agriculture & Veterinary
1
Clinical Aspects, Treatment & Prevention
1
Europe
1
Treatment & Prevention
1
Clinical Aspects
1
Influenza Prevention & Control
1
Diagnosis & Treatment PTSD in Children
1
Pediatrics
1
Information for Refugees & Migrants
1
Neuropsychology of Trauma
1
Hepatitis
1
Public Health
1
HIV
1
TB
1
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
1
Children/Adolescents Mental Disorders
1
Clinical aspects
1
Mental Health Guidelines
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Context & Facts, Travel Advice
1
Online Courses & Resources
1
COVID-19
1
Public Health
1
PPE Personel Protective Equipment
1
Video & Audio
1
For People with Disabilities
1
Appeals and Response Plans
1
Dashboards & Maps
1
Resource Platforms others
1
Gender Aspects
1
Paediatrics
1
COVID-19
1
Hospital Readiness/Essential Health Services
1
Non-pharmaceutical interventions (NPIs)
1
Long-term Care Facilities
1
TB/HIV
1
Genomic sequencing
1
TB/COVID-19
1
Sputnik V
1
Chile
1
Essential Medicines
1
Prices and Patents
1
Pharmacy Practice
1
Supply Chain & Store Management
1
Rational use of Medicine
1
Traditional & Herbal Medicines
1
General Guidelines for Rational Use
1
Ukraine
1
Zoonoses
1
MPOX - Monkeypox
1
MPOX - Monkeypox
1
MPOX -Monkeybox Prevention & Control
1
Strategies & Roadmaps
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Dracunculiasis (guinea-worm disease)
1
General Information
1
Prevention & Strategies
1
Studies & Reports
1
Studies & Reports
1
Women
1
Global Overview
1
Detection & Diagnosis
1
Co-Morbidities (except TB)
1
Human Rights & the Right to Health
1
Nutrition
1
Technical Information
1
TB/HIV Coinfection
1
Clinical Guidelines
1
Anxiety Disorders
1
Global Health Institutions and Stakeholders
1
Antiretroviral Treatment ART
1
TB
1
War, Conflict Areas & Refugees
1
Depression
1
Studies & Reports
1
PhD Martin Moder, österreichischer Molekularbiologe, Autor populärwissenschaftlicher Bücher und Teil der Wissenschaftskabarettgruppe Science Busters, erklärt die Wirkweise und potentiellen Risiken der mRNA-Impfstoffe gegen COVID19
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
Februrar 2021
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
Diese Faktenboxen sollen Ihnen helfen, Nutzen und Schaden einer Schutzimpfung gegen COVID-19 abzuwägen. Die Informationen und Zahlen stellen keine endgültige Bewertung dar. Sie basieren auf den derzeit besten wissenschaftlichen Erkenntnissen.
mRNA vaccines have to potential to end the COVID19 pandemic. How do they work? Are they safe? And how could they've been developed so quickly?
How COVID-19 mRNA Vaccines Work
recommended
COVID-19 mRNA vaccines deliver directions to make a protein that educates our immune system, so it will neutralize the virus in future encounters. The mRNA-containing lipid particles are taken up by specialized immune system cells
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna
Stand 21. Dezember 2021
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna
orientations provisoires, première publication le 25 janvier 2021, mise à jour le 15 juin 2021, mise à jour le 19 novembre 2021
(Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та Spikevax® виробництва Moderna);
Anamnese zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit mRNA-Impfstoffen –
(Comirnaty® 10 μg bzw. ...
– (Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit mRNA-Impfstoffen –
(Comirnaty® 10 μg bzw. 30 μg von BioNTech/Pfizer...
mRNA technologies. What is their future and scope, and what are the challenges that countries might face in rolling them out? Hello and welcome to Science in5. I'm Vismita Gupta-Smith. We are talking to Dr.Soumya Swaminathan today. Soumya, talk to us about mRNA technologies. What is the future?
